Literature DB >> 22777288

Prostate cancer: unravelling AR splice variant signalling in CPRC.

Annette Fenner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22777288     DOI： 10.1038/nrurol.2012.139

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.

Authors:  Rong Hu; Changxue Lu; Elahe A Mostaghel; Srinivasan Yegnasubramanian; Meltem Gurel; Clare Tannahill; Joanne Edwards; William B Isaacs; Peter S Nelson; Eric Bluemn; Stephen R Plymate; Jun Luo
Journal:  Cancer Res       Date:  2012-06-18       Impact factor: 12.701
  1 in total
  3 in total

1.  Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer.

Authors:  Fangfang Qu; Wanling Xie; Mari Nakabayashi; Haitao Zhang; Seong Ho Jeong; Xiaodong Wang; Kazumasa Komura; Christopher J Sweeney; Oliver Sartor; Gwo-Shu Mary Lee; Philip W Kantoff
Journal:  Clin Cancer Res       Date:  2016-08-03       Impact factor: 12.531

2.  Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness.

Authors:  Maria Kashat; Lyna Azzouz; Shaan H Sarkar; Dejuan Kong; Yiwei Li; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

Review 3.  Molecular and cellular mechanisms of castration resistant prostate cancer.

Authors:  Yiqiao Huang; Xianhan Jiang; Xue Liang; Ganggang Jiang
Journal:  Oncol Lett       Date:  2018-02-27       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.